UK: Bupa Health Clinics picks up Blackberry Clinics
Bupa Health Clinics has acquired Blackberry Clinics, specialists in treating muscle, bone and joint conditions.
This month, some 22 Blackberry Clinics will join the Bupa...
UK: Immunocore prices upsized convertible notes
Oxford-based Immunocore Holdings, a clinical-stage T cell receptor biotech company, last week priced an upsized US$350m 2.50% convertible senior 144a notes issue due 2030...
UK: Six Physio finds perfect partners in Chelsea Home Physio
Six Physio, a specialist provider of physiotherapy with clinics across London, has acquired Chelsea Home Physio a provider of home physiotherapy operating across Central, West and South...
Sweden: Mahmood takes up CEO position at Acarix
Swedish medical device company, Acarix, has appointed Aamir Mahmood as its new CEO. He succeeds acting CEO Fred Colen and previous CEO Carnegie.
Mahmood has more...
Australia: PLG widens portfolio of offerings with acquisition of Commercial Eyes
France-headquartered ProductLife Group (PLG), a specialised global provider of regulatory, scientific, vigilance, quality and digital transformation consulting services for the life sciences industries, has...
France: Apposite Capital appoints Nguyen-Cluzel as senior advisor
Cecile Nguyen-Cluzel has been appointed as senior advisor at healthcare specialist PE investor, Apposite Capital.
She will focus on the French market, where Sam Gray,...
Belgium: VIVES IUF Fund secures €70m equity to catalyze science into start-ups
VIVES IUF, a European high-tech early-stage fund, has raised €38m (US$41.2M) in capital, bringing its total funding to €70m. The European Investment Fund (EIF)...
Ireland: Malin US investee company CG Oncology raises US$380m from IPO
Malin Corporation investee company, US-based CG Oncology, has priced its upsized IPO of 20,000,000 shares at US$19.00 per share to raise gross proceeds of US$380m....
UK: Verici Dx raises £6.22m from placement and opens retail offering
AIM-listed Verici Dx, a developer of advanced clinical diagnostics for organ transplant, has concluded a share placement of 69,111,111 shares at 9.0 pence per share...
France: Institut Mérieux targets 10% holding in Oxford Biomedica following sale of ABL Europe
London-listed CDMO Oxford Biomedica has completed the acquisition of pure-play European CDMO ABL Europe from family-owned holding company Institut Mérieux for €15m ((US$16.2m) -...
Advertisement
